Aprepitant/Fosaprepitant Dimeglumine and Dexrazoxane Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Dextenza Insert
- Aprepitant/Fosaprepitant Dimeglumine-Dextenza intraocular
- Aprepitant/Fosaprepitant Dimeglumine-Dextran 40
- Aprepitant/Fosaprepitant Dimeglumine-Dextran 70 6% in 5% Dextrose high molecular weight
- Aprepitant/Fosaprepitant Dimeglumine-Dextran 75
- Aprepitant/Fosaprepitant Dimeglumine-Dextran high molecular weight
- Dexrazoxane Intravenous-Apresazide
- Dexrazoxane Intravenous-Apresoline
- Dexrazoxane Intravenous-Apresoline Injection
- Dexrazoxane Intravenous-Apri
- Dexrazoxane Intravenous-Apriso
- Dexrazoxane Intravenous-Aprizio Pak